HMG-CoA
From Wikipedia, the free encyclopedia
This article does not cite any sources. (December 2009) (Learn how and when to remove this template message) |
Names | |
---|---|
IUPAC name
(9R,21S)-1-[(2R,3S,4R,5R)-5-
(6-amino-9H-purin-9-yl)-4-hydroxy- 3-(phosphonooxy)tetrahydrofuran-2-yl]- 3,5,9,21-tetrahydroxy-8,8,21-trimethyl- 10,14,19-trioxo-2,4,6-trioxa-18-thia- 11,15-diaza-3,5-diphosphatricosan-23- oic acid 3,5-dioxide |
|
Identifiers | |
1553-55-5 | |
3D model (Jmol) | Interactive image |
ChEBI | CHEBI:61659 |
ChemSpider | 392859 |
ECHA InfoCard | 100.014.820 |
3040 | |
MeSH | HMG-CoA |
PubChem | 445127 |
|
|
|
|
Properties | |
C27H44N7O20P3S | |
Molar mass | 911.661 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
verify (what is ?) | |
Infobox references | |
HMG-CoA (or 3-hydroxy-3-methylglutaryl-coenzyme A) is an intermediate in the mevalonate and ketogenesis pathways. It is formed from acetyl CoA and acetoacetyl CoA by HMG-CoA synthase. The researches of Minor J. Coon and Bimal Kumar Bachhawat in the 1950s at University of Illinois led to its discovery.[1][2]
It is also an intermediate in the metabolism of leucine. Its immediate precursor is 3-methylglutaconyl CoA.
Mevalonate pathway[edit]
Main article: Mevalonate pathway
HMG-CoA reductase converts it into mevalonic acid.
Ketogenesis pathway[edit]
HMG-CoA lyase breaks it into acetyl CoA and acetoacetate.
References[edit]
- ^ Debi P. Sarkar (2015). "Classics in Indian Medicine" (PDF). The National Medical Journal of India (28): 3.
- ^ Avadhesha Surolia (1997). "An outstanding scientist and a splendid human being" (PDF). Glycobiology. 7 (4): v–ix.
This biochemistry article is a stub. You can help Wikipedia by expanding it. |